106 related articles for article (PubMed ID: 24289610)
21. Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels.
Zhao Y; Zhang LL; Ding FX; Cao P; Qi YY; Wang J
Ren Fail; 2017 Nov; 39(1):159-165. PubMed ID: 27876426
[TBL] [Abstract][Full Text] [Related]
22. Association between the Ku70-1310C/G promoter polymorphism and cancer risk: a meta-analysis.
Xu L; Ju XB; Li P; Wang J; Shi ZM; Zheng MJ; Xue DD; Xu YJ; Yin YM; Wang S; You YP
Asian Pac J Cancer Prev; 2012; 13(2):683-7. PubMed ID: 22524845
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis.
Jing JJ; Li M; Yuan Y
Gene; 2012 May; 499(2):237-42. PubMed ID: 22441122
[TBL] [Abstract][Full Text] [Related]
24. A preliminary identification of PIN1 SNP linkage in patients with coronary heart disease from Handan, China.
Wang JZ; Zhang YH; Bai J; Du WT; Zhang XY
Rev Port Cardiol (Engl Ed); 2021 Feb; 40(2):133-139. PubMed ID: 33358249
[TBL] [Abstract][Full Text] [Related]
25. PIN1-842G/C and -667T/C polymorphisms are not associated with the susceptibility of Alzheimer's disease: pooled analysis of epidemiologic studies.
Cao L; Wang F; Ge H; Wu PC; Qu P; Chen GH; Gao ZL
Neurosci Lett; 2013 Feb; 535():100-3. PubMed ID: 23274710
[TBL] [Abstract][Full Text] [Related]
26. Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.
Zeng L; Luo S; Li X; Lu M; Li H; Li T; Wang G; Lyu X; Jia W; Dong Z; Jiang Q; Shen Z; Huang GL; He Z
Sci Rep; 2017 Jul; 7(1):4593. PubMed ID: 28676695
[TBL] [Abstract][Full Text] [Related]
27. Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters.
Naidu R; Har YC; Taib NA
Scand J Clin Lab Invest; 2011 Oct; 71(6):500-6. PubMed ID: 21745146
[TBL] [Abstract][Full Text] [Related]
28. PIN1 promoter polymorphisms are associated with Alzheimer's disease.
Segat L; Pontillo A; Annoni G; Trabattoni D; Vergani C; Clerici M; Arosio B; Crovella S
Neurobiol Aging; 2007 Jan; 28(1):69-74. PubMed ID: 16384626
[TBL] [Abstract][Full Text] [Related]
29. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis.
Mao X; Ke Z; Liu S; Tang B; Wang J; Huang H; Chen S
Gene; 2015 Nov; 573(1):75-83. PubMed ID: 26169021
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
31. Association between rs1862513 and rs3745367 Genetic Polymorphisms of Resistin and Risk of Cancer: A Meta-Analysis.
Hashemi M; Bahari G; Tabasi F; Moazeni-Roodi A; Ghavami S
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2709-2716. PubMed ID: 30360595
[TBL] [Abstract][Full Text] [Related]
32. Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis.
Jiang HY; Zeng Y; Xu WD; Liu C; Wang YJ; Wang YD; Wang YD
Asian Pac J Cancer Prev; 2015; 16(9):3645-51. PubMed ID: 25987016
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 promoter gene polymorphisms and susceptibility to tuberculosis: a meta-analysis.
Gao X; Chen J; Tong Z; Yang G; Yao Y; Xu F; Zhou J
PLoS One; 2015; 10(6):e0127496. PubMed ID: 26030829
[TBL] [Abstract][Full Text] [Related]
34. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
35. PIN1 gene variants in Alzheimer's disease.
Maruszak A; Safranow K; Gustaw K; Kijanowska-Haładyna B; Jakubowska K; Olszewska M; Styczyńska M; Berdyński M; Tysarowski A; Chlubek D; Siedlecki J; Barcikowska M; Zekanowski C
BMC Med Genet; 2009 Nov; 10():115. PubMed ID: 19909517
[TBL] [Abstract][Full Text] [Related]
36. Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.
Chen Y; Wu YR; Yang HY; Li XZ; Jie MM; Hu CJ; Wu YY; Yang SM; Yang YB
Cell Death Dis; 2018 Aug; 9(9):883. PubMed ID: 30158600
[TBL] [Abstract][Full Text] [Related]
37. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
38. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M; Zou Y; Bai Y; Li M
J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
[TBL] [Abstract][Full Text] [Related]
39. Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis.
Yang L; Li N; Wang S; Kong Y; Tang H; Xie X; Xie X
Asian Pac J Cancer Prev; 2014; 15(12):4823-7. PubMed ID: 24998547
[TBL] [Abstract][Full Text] [Related]
40. BRD4 and PIN1 gene polymorphisms are associated with high pulse pressure risk in a southeastern Chinese population.
Qiu JJ; Yang RZ; Tang YJ; Lin YY; Xu HJ; Zhang N; Liang M; Cai HD; Zeng K; Wu XD
BMC Cardiovasc Disord; 2020 Nov; 20(1):475. PubMed ID: 33148187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
